These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9859737)

  • 1. [Withdrawal symptoms in connection with the use of selective serotonin reuptake inhibitors (SSRI)].
    Gram LF
    Ugeskr Laeger; 1998 Dec; 160(50):7291-3. PubMed ID: 9859737
    [No Abstract]   [Full Text] [Related]  

  • 2. [Severe withdrawal symptoms with fever upon stopping paroxetine].
    Bakker A
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1795; author reply 1795-6. PubMed ID: 10494333
    [No Abstract]   [Full Text] [Related]  

  • 3. [Selective serotonin reuptake inhibitors and mammary pathologies].
    Shchepotin IB; Zotov AS; Dobzhenko MN
    Vopr Onkol; 2010; 56(4):393-7. PubMed ID: 20968014
    [No Abstract]   [Full Text] [Related]  

  • 4. Neonatal complications after intrauterine exposure to SSRI antidepressants.
    Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The transfer of selective serotonin reuptake inhibitors to human milk].
    Nordeng H; Bergsholm YK; Bøhler E; Spigset O
    Tidsskr Nor Laegeforen; 2001 Jan; 121(2):199-203. PubMed ID: 11475200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine and serotonin toxicity.
    Isbister GK; Downes F; Whyte IM
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):241-2. PubMed ID: 12667176
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential withdrawal syndrome associated with SSRI discontinuation.
    Lazowick AL; Levin GM
    Ann Pharmacother; 1995 Dec; 29(12):1284-85. PubMed ID: 8672834
    [No Abstract]   [Full Text] [Related]  

  • 8. Discontinuation of antidepressant therapy: emerging complications and their relevance.
    Thompson C
    J Clin Psychiatry; 1998 Oct; 59(10):541-8. PubMed ID: 9818638
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antidepressive agents with only few serious adverse effects].
    Lakartidningen; 1993 Oct; 90(41):3568-9, 3571. PubMed ID: 8231504
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitor discontinuation symptoms.
    Mahendran R; Chan A
    Ann Acad Med Singap; 1999 Jul; 28(4):596-9. PubMed ID: 10561781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal.
    Silvestri R; Pace-Schott EF; Gersh T; Stickgold R; Salzman C; Hobson JA
    J Clin Psychiatry; 2001 Aug; 62(8):642-52. PubMed ID: 11561938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants in the postpartum period: additional considerations.
    Burbeck R; Pilling S; Tomson D; McDonald L
    Am J Psychiatry; 2008 Feb; 165(2):262-3; author reply 263. PubMed ID: 18245193
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitor discontinuation with ECT and withdrawal symptoms.
    Markowitz JS
    J ECT; 1998 Mar; 14(1):55. PubMed ID: 9661096
    [No Abstract]   [Full Text] [Related]  

  • 14. Antidepressant discontinuation: a review of the literature.
    Lejoyeux M; Adès J
    J Clin Psychiatry; 1997; 58 Suppl 7():11-5; discussion 16. PubMed ID: 9219488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of fetal anomalies with exposure to selective serotonin reuptake inhibitors.
    Grush LR
    JAMA; 1998 Jun; 279(23):1873. PubMed ID: 9634252
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonin discontinuation syndrome: does it really exist?
    Nuss S; Kincaid CR
    W V Med J; 2000; 96(2):405-7. PubMed ID: 10771628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Withdrawal syndrome after the use of serotonin reuptake inhibitors].
    Fagan M
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):913-4. PubMed ID: 10795494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitor. Discontinuation syndrome.
    Finfgeld DL
    J Psychosoc Nurs Ment Health Serv; 2002 Dec; 40(12):14-8. PubMed ID: 12491870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.
    Vandel P; Sechter D; Weiller E; Pezous N; Cabanac F; Tournoux A; Panconi E
    Hum Psychopharmacol; 2004 Dec; 19(8):585-6. PubMed ID: 15570574
    [No Abstract]   [Full Text] [Related]  

  • 20. SSRI withdrawal.
    Mareth TR; Brown TM
    J Clin Psychiatry; 1996 Jul; 57(7):310. PubMed ID: 8666577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.